You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Dow
Express Scripts
McKesson
Johnson and Johnson

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 5,217,905

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,217,905
Title: Device and method for the rapid qualitative and quantitative determination of the presence of a reactive ligand in a fluid
Abstract:A device for the rapid qualitative and quantitative determination of the presence of a reactive ligand in a fluid. This device comprises a first reaction zone in which there is an at least temporarily impermeable membrane designed to receive a sample of test fluid and to be associated with at least one labeled reagent; a second reaction zone which is bounded on the one hand by the said membrane and on the other by a second at least temporarily impermeable membrane comprising a solid phase containing a reference reagent; and a third reaction zone which contains means for developing the reaction. A method for the rapid qualitative and quantitative determination of the presence of a reactive ligand in a fluid. Applications to the detection of the presence, in a biological fluid, of antibodies or antigens in particular.
Inventor(s): Marchand; Joseph (Verrieres Le Buisson, FR), Toledano; Jacques (Paris, FR)
Assignee: Compagnie Oris Industrie S.A. (Gif-Sur-Yvette, FR) Cistest (Paris, FR)
Application Number:07/220,895
Patent Claims:see list of patent claims

Details for Patent 5,217,905

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Compagnie Oris Industrie S.A. (Gif-Sur-Yvette, FR) Cistest (Paris, FR) 2010-06-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
AstraZeneca
McKinsey
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.